”A high-case scenario of antimicrobial resistance (AMR) could cause low-income countries to lose more than 5% of their GDP (gross domestic product) and push up to 28 million people, mostly in developing countries, into poverty by 2050," the World Bank report revealed.
World Bank researchers concluded that the high cost of recovery measures would make it more difficult and expensive to rebuild economies affected by antimicrobial resistance than of those that were hit by the global financial crisis eight years ago.
The study suggested that about $9 billion annual funding for human and animal health could improve the forecast.
According to the World Health Organization, nearly 480 000 new cases of multidrug-resistant tuberculosis were registered in 2014. As of July this year, resistance to the first-line treatment for malaria had been confirmed in five countries – Cambodia, Laos, Myanmar, Thailand and Vietnam.
